IMMUNOLOGICAL STUDIES OF GAMMA-DELTA T-CELLS IN A CASE OF LARGE GRANULAR LYMPHOCYTE (LGL) LEUKEMIA - LEUKEMIC GAMMA-DELTA+ T-CELLS ARE RESISTANT TO GROWTH-STIMULATION INVITRO BUT RESPOND TO INTERFERON-ALPHA TREATMENT INVIVO

被引:21
作者
METZGER, R
HECKLOSTREICHER, B
NERL, C
SCHONDELMAIER, S
KABELITZ, D
机构
[1] UNIV HEIDELBERG,INST IMMUNOL,W-6900 HEIDELBERG,GERMANY
[2] STADT KRANKENHAUS,W-8000 MUNICH 40,GERMANY
关键词
GAMMA-DELTA T-CELL RECEPTOR; CHRONIC LYMPHOCYTIC LEUKEMIA; LARGE GRANULAR LYMPHOCYTE; T-CELL ACTIVATION; INTERLEUKINS; INTERFERON-ALPHA;
D O I
10.1016/0145-2126(92)90047-B
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Leukemic T cells from patient BU (WBC 22000/mul) resembled morphologically large granular lymphocytes, and expressed a Vdelta1-encoded gammadelta T-cell receptor (TCR) on their surface. Upon in vitro activation with various mitogens, IL-2-dependent Vdelta1+ cell lines were only obtained if Vdelta1+ cells had been positively selected on a cell sorter before culture. However, even under these conditions, the Vdelta1+ IL-2-dependent cell lines showed a TCR beta and gamma gene-rearrangement different from that of the freshly isolated leukemic cell population, indicating that they were not derived from the leukemic clone. Thus, known T-cell growth factors (IL-2, IL-4, IL-7) in concert with mitogenic signals failed to induce in vitro proliferation of the Vdelta1+ leukemic clone. Interestingly, the patient responded to treatment with interferon-alpha2c (daily dose of 10(6) I.U.). After 2 1/2 years of continuous interferon treatment, the patient is in partial remission with WBC around 8000/mul.
引用
收藏
页码:1087 / 1095
页数:9
相关论文
共 17 条
[1]  
ALFSEN GC, 1991, BLOOD, V77, P2023
[2]   BMA031, A MONOCLONAL-ANTIBODY SUITED TO IDENTIFY THE T-CELL RECEPTOR ALPHA-BETA/CD3 COMPLEX ON VIABLE HUMAN LYMPHOCYTES-T IN NORMAL AND DISEASE STATES [J].
BORST, J ;
VANDONGEN, JJM ;
DEVRIES, E ;
COMANSBITTER, WM ;
VANTOL, MJD ;
VOSSEN, JM ;
KURRLE, R .
HUMAN IMMUNOLOGY, 1990, 29 (03) :175-188
[3]  
COLAMONICI OR, 1988, J IMMUNOL, V140, P2527
[4]  
DYER MJS, 1989, BLOOD, V74, P1073
[5]  
FALINI B, 1989, BLOOD, V74, P2501
[6]   ACUTE-LEUKEMIA EXPRESSING THE GAMMA GENE-PRODUCT OF THE PUTATIVE 2ND T-CELL RECEPTOR [J].
GONZALEZSARMIENTO, R ;
LEBIEN, TW ;
BRADLEY, JG ;
GREENBERG, JM ;
SEIDMAN, JG ;
ANG, S ;
KERSEY, JH .
JOURNAL OF CLINICAL INVESTIGATION, 1987, 79 (04) :1281-1284
[7]   PROVOCATIVE PATTERN OF REARRANGEMENTS OF THE GENES FOR THE GAMMA-CHAIN AND BETA-CHAIN OF THE T-CELL RECEPTOR IN HUMAN LEUKEMIAS [J].
GOORHA, R ;
BUNIN, N ;
MIRRO, J ;
MURPHY, SB ;
CROSS, AH ;
BEHM, FG ;
QUERTERMOUS, T ;
SEIDMAN, J ;
KITCHINGMAN, GR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (13) :4547-4551
[8]  
JANSSEN O, 1991, J IMMUNOL, V146, P35
[9]   ACTIVATION AND ACTIVATION-DRIVEN DEATH OF HUMAN GAMMA/DELTA T-CELLS [J].
KABELITZ, D ;
PECHHOLD, K ;
BENDER, A ;
WESSELBORG, S ;
WESCH, D ;
FRIESE, K ;
JANSSEN, O .
IMMUNOLOGICAL REVIEWS, 1991, 120 :71-88
[10]   REARRANGEMENT OF 2 DISTINCT T-CELL GAMMA-CHAIN VARIABLE-REGION GENES IN HUMAN DNA [J].
LEFRANC, MP ;
FORSTER, A ;
RABBITTS, TH .
NATURE, 1986, 319 (6052) :420-422